![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Baran D.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.60, Iss.5, 2000-11, pp. : 997-1016
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
-Blockers For Congestive Heart Failure: What is the Current Consensus?
By Tsuyuki R.T.
Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Impact of Home Patient Telemonitoring on Use of β-Blockers in Congestive Heart Failure
Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Underutilisation of ACE Inhibitors in Patients with Congestive Heart Failure
By Bungard T.J.
Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Differential effects of theophylline in congestive heart failure
Inpharma, Vol. 1, Iss. 1461, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Optimising the Use of -Blockers in Older Patients with Heart Failure
By Owen A.
Drugs & Aging, Vol. 19, Iss. 9, 2002-01 ,pp. :